Characteristic | n (%) |
---|---|
Age group | Â |
<30 | 34 (11.5) |
30 – 39 | 96 (32.5) |
40 – 49 | 94 (31.9) |
50 – 59 | 59 (20.0) |
>60 | 12 (4.1) |
Sex | Â |
Male | 89 (30.2) |
Female | 206 (69.8) |
CD4 count | Â |
<200 | 143 (48.5) |
>200 | 152 (51.5) |
CDC staging categories | Â |
A1 | 8 (2.7) |
A2 | 36 (12.2) |
A3 | 31 (10.5) |
B1 | 4 (1.2) |
B2 | 73 (24.8) |
B3 | 67 (22.7) |
C1 | 6 (2.0) |
C2 | 27 (9.2) |
C3 | 43 (14.6) |
HAART regimen | Â |
AZT-3TC-EFV | 46 (15.6) |
AZT-3TC-NVP | 134 (45.4) |
TDF-3TC-EFV | 22 (7.5) |
TDF-FTC-EFV | 4 (1.4) |
D4T-3TC-NVP | 46 (15.6) |
Others | 34 (11.5) |
Not treated | 9 (3.1) |
History of anti-tuberculosis treatment | Â |
Yes | 31 (10.5) |
No | 264 (89.5) |
History of alcohol intake | Â |
Yes | 33 (11.2) |
No | 262 (88.8) |